Objective To evaluate the hospital survival in patients with severe ARDS managed with
ECMO and low tidal volume ventilation as compared to patients managed with low tidal …

The high mortality rate of patients with severe acute respiratory distress syndrome (ARDS)
warrants aggressive clinical intervention. Extracorporeal membrane oxygenation (ECMO) is …

The use of extracorporeal membrane oxygenation (ECMO) in severe acute respiratory
distress syndrome (ARDS) has increased considerably over the last several years …

Background COVID‐19 can lead to acute respiratory distress syndrome (ARDS).
Extracorporeal membrane oxygenation (ECMO) is considered to be a salvage strategy for …

Background No definitive conclusions have been drawn from the available data about the
utilization of extracorporeal membrane oxygenation (ECMO) to treat severe acute respiratory …

Background The efficacy of venovenous extracorporeal membrane oxygenation (ECMO) in
patients with severe acute respiratory distress syndrome (ARDS) remains controversial …

Background: Extracorporeal membrane oxygenation (ECMO) has emerged as a newer
method for managing severe acute respiratory distress syndrome (ARDS) and ARDS …

Before widespread diffusion of VV-ECMO for severe ARDS, new trials should test the
efficacy of early initiation of the technique with tight control of mechanical ventilation in the …

The acute respiratory distress syndrome (ARDS) remains associated with an elevated rate of
mortality that may exceed 60% in the most severe cases with a refractory hypoxemia. In …

Purpose To assess the effect of venovenous extracorporeal membrane oxygenation (ECMO)
compared to conventional management in patients with severe acute respiratory distress …